Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01154075 · ClinicalTrials.gov registry record
Medication Adherence in Children Who Had a Liver Transplant
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 401
- Enrollment target
NCT01154075: Completed study, sponsored by Icahn School of Medicine at Mount Sinai.
NCT01154075 is a clinical trial that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 401 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01154075 has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 401 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the use of a novel method to measure adherence to immunosuppressant medications in predicting rejection episodes in children who had a liver transplant.
Primary Outcome
Adherence measured through the use of the standard deviation of a series of tacrolimus blood levels obtained during the course of follow-up is the primary predictor.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 401 participants |
| Start Date | 2010-08 |
| Est. Completion | 2015-06 |
What the finished NCT01154075 record still lists
NCT01154075 is an observational study that tracks outcomes without assigning an intervention. The registered 401 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01154075 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01154075 about?
NCT01154075 is a clinical study titled "Medication Adherence in Children Who Had a Liver Transplant". The purpose of this study is to evaluate the use of a novel method to measure adherence to immunosuppressant medications in predicting rejection episodes in children who had a liver transplant.
What is the current status of trial NCT01154075?
This trial is currently completed. The enrollment target is 401 participants. The study started on 2010-08. Estimated completion is 2015-06.
Who is sponsoring clinical trial NCT01154075?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04464226 · 402 participants · Phase 3
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
- NCT05183763 · 402 participants · NA
Medication Adherence Program
- NCT06748222 · 402 participants · Phase 3
E-Mindfulness Approaches for Living After Breast Cancer
- NCT06896474 · 402 participants · NA
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia